跳至主要内容
临床试验/ACTRN12618001810202
ACTRN12618001810202招募中未知

Development of imaging biomarkers for accurate and informative assessment of treatment outcome following prostate radiotherapy. The BiRT Sequential Imaging” project (SI-BiRT).

niversity of Sydney0 个研究点目标入组 30 人开始时间: 2018年11月6日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Male

入选标准

  • Biopsy proven localised prostate cancer.
  • Great than or equal to 18 years of age.
  • Willing and able to comply with all study requirements.
  • Signed, written and informed consent.
  • Completed MRI safety screening as per local policy.
  • Up to 4 months ADT prior to radiotherapy.
  • No more than 20 participants who receive ADT.

排除标准

  • Mentally impaired participants or participants for who obtaining informed consent would be difficult.
  • Unable to undergo an MRI examination or has contraindications to MRI.
  • Inadequate renal function for contrast administration (eGFR <60 ml/min) at baseline imaging.
  • Participants who have been clinically diagnosed with severe claustrophobia.
  • Prior pelvic radiotherapy.
  • Any prosthetic implants such as metallic hip prostheses that may cause artefacts in the imaging studies.

研究者

相似试验